zoledronic acid has been researched along with Diabetes Mellitus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Hu, Q; Liu, F; Wang, Q; Yao, L; Zhang, L | 1 |
| Bi, W; Dong, W; Jia, S; Liang, Y; Qi, M; Song, Z; Wen, G; Xie, S; Zhang, Y | 1 |
| Bohle, G; Chou, JF; Estilo, CL; Halpern, J; Hansen, HJ; Huryn, JM; Riedel, E; Tunick, S; Watters, AL; Williams, T | 1 |
1 trial(s) available for zoledronic acid and Diabetes Mellitus
| Article | Year |
|---|---|
Combination of Calcitriol and Zoledronic Acid on PINP and
Topics: Calcitriol; Diabetes Mellitus; Fractures, Avulsion; Humans; Osteoporosis; Pain; Tibial Fractures; Treatment Outcome; Zoledronic Acid | 2022 |
2 other study(ies) available for zoledronic acid and Diabetes Mellitus
| Article | Year |
|---|---|
Zoledronate Promotes Peri-Implant Osteogenesis in Diabetic Osteoporosis by the AMPK Pathway.
Topics: AMP-Activated Protein Kinases; Animals; Cell Differentiation; Diabetes Mellitus; Glucose; Osteoblasts; Osteogenesis; Osteoporosis; Rats; X-Ray Microtomography; Zoledronic Acid | 2023 |
Intravenous bisphosphonate-related osteonecrosis of the jaw: long-term follow-up of 109 patients.
Topics: Adult; Aged; Aged, 80 and over; Bisphosphonate-Associated Osteonecrosis of the Jaw; Chi-Square Distribution; Comorbidity; Diabetes Mellitus; Diphosphonates; Disease Progression; DMF Index; Female; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; New York City; Pamidronate; Risk Factors; Smoking; Zoledronic Acid | 2013 |